Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



All endemic communities of the Oaxaca focus of onchocerciasis in southern Mexico have been treated annually or semi-annually with ivermectin since 1994. In-depth epidemiologic assessments were performed in communities during 2007 and 2008. None of the 52,632 s.l. collected in four sentinel communities was found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA), resulting in an upper bound of the infection rate in the vectors of 0.07/2,000. The prevalence of microfilariae (mf) in the cornea and/or anterior chamber of the eye was also zero (0 of 1,039 residents examined; 95%-UL = 0.35%). Similarly, all 1,164 individuals examined by skin biopsy were mf negative (95%-UL = 0.31%), and sera collected from 3,569 children from 25 communities did not harbor Ov16 IgG4-antibodies (95%-UL = 0.09%). These meet the criteria for absence of morbidity and parasite transmission in the Oaxaca focus. As a result mass treatments with ivermectin were halted in 2009.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. OEPA, 2008. Onchocerciasis Elimination Program for the Americas. Available at: http://www.oepa.net/index.html. Accessed November 15, 2009. [Google Scholar]
  2. Vásquez-Castellanos JL, , 1991. Cafeticultura e historia social de la oncocercosis en el Soconusco, estado de Chiapas, México. Salud Publica Mex 33: 124135. [Google Scholar]
  3. Pardo R, , 1927. A Propósito de los ciegos de Tiltepec. Gac Med Mex 58: 195. [Google Scholar]
  4. World Health Organization, 2001. Certification of Elimination of Human Onchocerciasis: Criteria and Procedures. Geneva, Switzerland: World Health Organization. [Google Scholar]
  5. Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, Dominguez A, Cruz-Ortiz N, Unnasch TR, Punkosdy GA, Richards J, Sauerbrey M, Castro J, Catu E, Oliva O, Richards FO, Jr, 2007. Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 77: 334341. [Google Scholar]
  6. Rodríguez-Pérez MA, Lilley BG, Domínguez-Vázquez A Segura-Arenas R, Lizarazo-Ortega C, Mendoza-Herrera A, Reyes-Villanueva F, Unnasch TR, , 2004. Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico. Am J Trop Med Hyg 70: 3845. [Google Scholar]
  7. Walsh JF, Davies JB, Le Berre LE, Garms R, , 1978. Standardization of criteria for assessing the effects of Simulium control in onchocersiasis control programmes. Trans R Soc Trop Med Hyg 72: 675676.[Crossref] [Google Scholar]
  8. Rodríguez-Pérez MA, Rodríguez MH, Margeli-López HM, Rivas-Alcalá AR, , 1995. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am J Trop Med Hyg 52: 429434. [Google Scholar]
  9. Cupp EW, Ochoa JO, Collins RC, Cupp MS, Gonzales-Peralta C, Castro J, Zea-Flores G, , 1992. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 47: 170180. [Google Scholar]
  10. Rodríguez-Pérez MA, Katholi CR, Hassan HK, Unnasch TR, , 2006. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am J Trop Med Hyg 74: 10261033. [Google Scholar]
  11. Katholi CR, Toé L, Merriweather A, Unnasch TR, , 1995. Determining the prevalence of Onchocerca volvulus infection in vector populations by PCR screening of pools of black flies. J Infect Dis 172: 14141417.[Crossref] [Google Scholar]
  12. Williams CB, , 1937. The use of logarithms in the interpretation of certain entomological problems. Ann Appl Biol 24: 404414.[Crossref] [Google Scholar]
  13. Rodríguez-Pérez MA, Lutzow-Steiner MA, Cabrera AS, Lizarazo-Ortega C, Domínguez-Vázquez A, Sauerbrey M, Richards F, Jr Unnasch TR, Hassan HK, Hernández-Hernández R, , 2008. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico achieved by quarterly treatments with Mectizan. Am J Trop Med Hyg 79: 239244. [Google Scholar]
  14. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB, , 1991. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science 251: 16031605.[Crossref] [Google Scholar]
  15. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, Boatin B, Weil GJ, Nutman TB, , 2006. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis 194: 216221.[Crossref] [Google Scholar]
  16. Armitage P, Berry G, , 1994. Statistical Methods in Medical Research. Third edition. Oxford: Blackwell Scientific Publications. [Google Scholar]
  17. Sauerbrey M, , 2008. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 102 (Suppl 1): 2529.[Crossref] [Google Scholar]
  18. Gonzalez RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A, Sauerbrey M, Catú E, Oliva O, Richards FO, Lindblade KA, , 2009. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis 3: e404.[Crossref] [Google Scholar]
  19. Cruz-Ortiz N, Rizzo N, Gonzalez R, Sauerbrey M, Zea-Flores G, Dominguez A, Oliva O, Catu E, Castro J, Lindblade KA, , 2008. Evaluación Entomológica, Serológica y Oftalmológica para Demostrar la Eliminación de la Transmisión de Onchocerca volvulus en el Foco de Huehuetenango. Guatemala: CDC-CAP. [Google Scholar]
  20. 2009. Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November, 2008. Wkly Epidemiol Rec 84: 385396. [Google Scholar]
  21. Rodríguez-Pérez MA, Unnasch TR, Domínguez-Vázquez A, Morales-Castro AL, Richards F, Jr Peña-Flores GP, Orozco-Algarra ME, Prado-Velasco G, , 2010. Lack of active Onchocerca volvulus transmission in the Northern Chiapas focus, Mexico. Am J Trop Med Hyg 83: 1520.[Crossref] [Google Scholar]
  22. Martin-Tellaeche A, Ramirez-Hernandez J, Santos-Preciado JI, Mendez-Galvan J, , 1998. Onchocerciasis: changes in transmisión in Mexico. Ann Trop Med Parasitol 92: S117S119.[Crossref] [Google Scholar]
  23. Rodríguez-Pérez MA, Lizarazo-Ortega C, Hassan HK, Domínguez-Vázquez A, Méndez-Galván J, Lugo-Moreno BP, Sauerbrey M, Richards F, Jr Unnasch TR, , 2008. Evidence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico. Am J Trop Med Hyg 78: 147152. [Google Scholar]
  24. Wada Y, , 1982. Theoretical approach to the epidemiology of onchocerciasis in Guatemala. Jpn J Med Sci Biol 35: 183196.[Crossref] [Google Scholar]
  25. Porter CH, Collins RC, Brandling-Bennett AD, , 1988. Vector density, parasite prevalence, and transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 39: 567574. [Google Scholar]
  26. Weil GJ, Steel C, Liftis F, Li B-W, Mearns G, Lobos E, Nutman TB, , 2000. A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis 182: 17961799.[Crossref] [Google Scholar]
  27. Rodriguez-Perez MA, Danis-Lozano R, Rodriguez MH, Bradley JE, , 1999. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico. Trop Med Int Health 4: 98104.[Crossref] [Google Scholar]
  28. Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, Proaño R, López AA, Guderian RH, Rumbea J, , 2007. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med 5: 9.[Crossref] [Google Scholar]
  29. Collins RC, Ochoa JO, Cupp EW, Gonzales-Peralta C, Porter CH, , 1992. Microepidemiology of onchocerciasis in Guatemala: dispersal and survival of Simulium ochraceum . Am J Trop Med Hyg 47: 147155. [Google Scholar]

Data & Media loading...

  • Received : 11 Sep 2009
  • Accepted : 22 Nov 2009
  • Published online : 06 Jul 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error